Safety Study of New Drug in Healthy Adults
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and in generally good health with no serious medical conditions
- Your body mass index (BMI) is between 18–30, and you weigh at least 50 kg (men) or 45 kg (women)
- You agree to use effective birth control during the study and for 12 weeks after your last dose if you or your partner can have children
- You have not donated blood or had significant blood loss in the past 2 months
- You do not have a history of allergies to multiple drugs, foods, or common environmental triggers
- You do not smoke more than 5 cigarettes per week and can stop tobacco use during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This trial tests different doses of a new study drug in healthy people to see how safe it is and how the body handles it. Participation involves taking the drug and having regular check-ups.
This early-stage study tests whether a new drug called FB102 is safe in people without serious health conditions. Researchers will monitor volunteers closely to understand how the body handles the drug.
Hear when a new Healthy Participants Study trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.